Cargando…

Biotransformation and metabolite elucidation of xenobiotics /

The goal of this book is to improve the readers' knowledge of metabolite elucidation in drug metabolism by exposing them to in depth coverage of the biotransformation of xenobiotics, strategies for identifying and characterizing metabolites, FDA guidelines, and case studies on how to improve th...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Nassar, Ala F.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken, N.J. : John Wiley & Sons, ©2010.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn669165475
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 101008s2010 nju ob 001 0 eng d
010 |z  2010016629 
040 |a DG1  |b eng  |e pn  |c DG1  |d N$T  |d EBLCP  |d DG1  |d OCLCQ  |d MHW  |d CUS  |d E7B  |d YDXCP  |d CDX  |d UBY  |d OCLCQ  |d REDDC  |d OCLCQ  |d OCLCF  |d OCLCQ  |d NLGGC  |d OCLCO  |d DEBSZ  |d OCLCO  |d OCLCQ  |d OCLCO  |d COO  |d OCLCO  |d OCLCQ  |d OCLCO  |d DEBBG  |d AZK  |d LOA  |d OCLCO  |d OCLCA  |d OCL  |d DG1  |d CHVBK  |d OCLCO  |d MOR  |d LIP  |d OCLCO  |d PIFAG  |d ZCU  |d OCLCO  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d OCL  |d GILDS  |d OCLCO  |d OCLCQ  |d STF  |d WRM  |d COCUF  |d NRAMU  |d ICG  |d INT  |d VT2  |d OCLCQ  |d WYU  |d OCLCA  |d OCLCQ  |d OCLCO  |d DKC  |d OCLCQ  |d UX1  |d OCLCQ  |d OCLCA  |d UKCRE  |d VLY  |d UKAHL  |d VHC  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCL 
019 |a 680628050  |a 696398143  |a 702004470  |a 961546548  |a 962615315  |a 966262704  |a 988455105  |a 991956591  |a 1037942838  |a 1038671518  |a 1045486825  |a 1055356305  |a 1064883687  |a 1081207152  |a 1153471769  |a 1162328905  |a 1228619708  |a 1290048883  |a 1303456946 
020 |a 9780470890387 
020 |a 047089038X 
020 |a 9780470890370  |q (electronic bk.) 
020 |a 0470890371  |q (electronic bk.) 
020 |z 9780470504789 
020 |z 0470504781 
020 |a 1118097777 
020 |a 9781118097779 
020 |a 1282782894 
020 |a 9781282782891 
020 |a 9786612782893 
020 |a 6612782897 
024 7 |a 10.1002/9780470890387  |2 doi 
029 1 |a AU@  |b 000046755791 
029 1 |a AU@  |b 000053276923 
029 1 |a AU@  |b 000058016895 
029 1 |a CHBIS  |b 010880521 
029 1 |a CHNEW  |b 000936632 
029 1 |a CHVBK  |b 48016939X 
029 1 |a DEBBG  |b BV043392264 
029 1 |a DEBBG  |b BV044147122 
029 1 |a DEBSZ  |b 430893469 
029 1 |a DEBSZ  |b 48499350X 
029 1 |a HEBIS  |b 299814882 
029 1 |a NZ1  |b 14255579 
029 1 |a AU@  |b 000068460233 
035 |a (OCoLC)669165475  |z (OCoLC)680628050  |z (OCoLC)696398143  |z (OCoLC)702004470  |z (OCoLC)961546548  |z (OCoLC)962615315  |z (OCoLC)966262704  |z (OCoLC)988455105  |z (OCoLC)991956591  |z (OCoLC)1037942838  |z (OCoLC)1038671518  |z (OCoLC)1045486825  |z (OCoLC)1055356305  |z (OCoLC)1064883687  |z (OCoLC)1081207152  |z (OCoLC)1153471769  |z (OCoLC)1162328905  |z (OCoLC)1228619708  |z (OCoLC)1290048883  |z (OCoLC)1303456946 
037 |a 10.1002/9780470890387  |b Wiley InterScience  |n http://www3.interscience.wiley.com 
050 4 |a QP529  |b .B583 2010 
060 4 |a QU 120  |b B6166 2011 
072 7 |a MED  |x 096000  |2 bisacsh 
082 0 4 |a 615.9  |2 22 
049 |a UAMI 
245 0 0 |a Biotransformation and metabolite elucidation of xenobiotics /  |c edited by Ala F. Nassar. 
260 |a Hoboken, N.J. :  |b John Wiley & Sons,  |c ©2010. 
300 |a 1 online resource (xi, 328 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
505 0 |a Frontmatter -- Human Biotransformation / Andrew Parkinson, Brian W Ogilvie, Brandy L Paris, Tiffini N Hensley, Greg J Loewen -- Analytical Tools and Approaches for Metabolite Identification in Drug Metabolism / Yongmei Li -- Tools of Choice for Accelerating Metabolite Identification: Mass Spectrometry Technology Drives Metabolite Identification Studies Forward / Ala F Nassar -- Improving Drug Design: Considerations for the Structural Modification Process / Ala F Nassar -- Case Study: The Unanticipated Loss of N from Novel DNA Alkylating Agent Laromustine by Collision-Induced Dissociation: Novel Rearrangements / Ala F Nassar, Jing Du, David Roberts, Kevin Lin, Mike Belcourt, Ivan King, Tukiet T Lam -- Case Study: Identification of Metabolite/Decomposition Products of the Novel DNA Alkylating Agent Laromustine / Ala F Nassar, Jing Du, David Roberts, Kevin Lin, Mike Belcourt, Ivan King, Tukiet T Lam -- Strategies for the Detection of Reactive Intermediates in Drug Discovery and Development / Mark P Grillo -- Safety Testing of Drug Metabolites: Mist Guidance Impact on the Practice of Industrial Drug Metabolism / J Greg Slatter -- Index. 
504 |a Includes bibliographical references and index. 
505 0 |a Human biotransformation / Andrew Parkinson -- Analytical tools and approaches for metabolite identification in drug metabolism / Yongmei Li -- Tools of choice for accelerating metabolite identification : mass spec technology drives metabolite identification studies forward / Ala Nassar -- Improving drug design : considerations for the structural modification process / Ala Nassar -- Case study : the unanticipated loss of N2 from novel dna alkylating agent laromustine by collision-induced dissociation : novel rearrangements / Ala Nassar, Tukiet T. Lam -- Case study : identification of in vitro metabolite/decomposition products of the novel DNA alkylating agent laromustine / Ala Nassar, TuKiet T. Lam -- Strategies for the detection of reactive intermediates in drug discovery and development / Mark P. Grillo -- Safety testing of drug metabolites : MIST guidance impact on the practice of industrial drug metabolism / J. Greg Slatter. 
520 |a The goal of this book is to improve the readers' knowledge of metabolite elucidation in drug metabolism by exposing them to in depth coverage of the biotransformation of xenobiotics, strategies for identifying and characterizing metabolites, FDA guidelines, and case studies on how to improve the decision-making process in structural modification of drug candidates to reduce toxicity. The book consists of 8 chapters; it first provides an introduction on biotransformation of xenobiotics, and then presents modern approaches and strategies for dealing with metabolite characterization, using tools. 
588 0 |a Print version record. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Xenobiotics  |x Metabolism. 
650 0 |a Metabolites  |x Identification. 
650 0 |a Biotransformation (Metabolism) 
650 0 |a Metabolites  |v Identification. 
650 2 |a Xenobiotics  |x metabolism 
650 2 |a Xenobiotics  |x pharmacology 
650 2 |a Biotransformation  |x physiology 
650 2 |a Drug Discovery 
650 2 |a Biotransformation 
650 6 |a Xénobiotiques  |x Métabolisme. 
650 6 |a Métabolites  |v Identification. 
650 6 |a Biotransformation (Métabolisme) 
650 6 |a Métabolites  |x Identification. 
650 7 |a MEDICAL  |x Toxicology.  |2 bisacsh 
650 7 |a Biotransformation (Metabolism)  |2 fast 
650 7 |a Metabolites  |2 fast 
650 7 |a Xenobiotics  |x Metabolism  |2 fast 
655 7 |a Field guides  |2 fast 
700 1 |a Nassar, Ala F. 
758 |i has work:  |a Biotransformation and metabolite elucidation of xenobiotics (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCFqJYTKWGYbtcjhcKQwJym  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Biotransformation and metabolite elucidation of xenobiotics.  |d Hoboken, N.J. : John Wiley & Sons, ©2010  |z 9780470504789  |w (DLC) 2010016629  |w (OCoLC)612188534 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=589068  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH21623728 
938 |a Coutts Information Services  |b COUT  |n 15486954 
938 |a EBL - Ebook Library  |b EBLB  |n EBL589068 
938 |a ebrary  |b EBRY  |n ebr10419055 
938 |a EBSCOhost  |b EBSC  |n 342706 
938 |a YBP Library Services  |b YANK  |n 3492415 
938 |a YBP Library Services  |b YANK  |n 3320671 
938 |a YBP Library Services  |b YANK  |n 12670240 
994 |a 92  |b IZTAP